Volume 6, Issue 2 (May 2018)                   Res Mol Med (RMM) 2018, 6(2): 29-35 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Vatandoost J, Azimifar M A. Expression of Recombinant Factor IX Using the Transient Gene Expression Technique. Res Mol Med (RMM) 2018; 6 (2) :29-35
URL: http://rmm.mazums.ac.ir/article-1-270-en.html
1- Department of Biology, Hakim Sabzevari University, Sabzevar , j.vatan@hsu.ac.ir
2- Department of Biotechnology, Sabzevar Branch, Islamic Azad University, Sabzevar, Iran
Abstract:   (2968 Views)
Background: Pilot and large-scale production of recombinant proteins require the presence of stable clones, but the process of selecting stable clones is time consuming. Moreover, continuous clone culturing in large-scale production may cause loss of incoming plasmid and recombinant genes.
Considering the advancements in Transient Gene Expression (TGE) technology, the large-scale expression of factor IX (FIX) was investigated in HEK cells by the TGE technique.
Materials and methods: HEK cells were seeded in a cell factory, and then transfected by pcDNA-hFIX plasmid using calcium phosphate co-precipitation method. Stable HEK-hFIX cells were also seeded in a cell factory, separately. After adding vitamin K, recombinant FIX was quantified in conditioned media using an ELISA. Moreover, its functional activity was assayed using an aPTT test.
Results: The results showed that the expression and activity of FIX by TGE technology was, respectively, 1.6 and 1.5 times higher than that obtained through stable HEK-FIX cells. Since calculating the specific activity revealed that for all time periods it is 0.2 mU/ng, so the increase in activity is due to the increase in the amount of FIX.
Conclusions: HEK cells with higher transfectability seemed to be an appropriate alternative for transient expression for large-scale protein production. Furthermore, if rapid expression of recombinant proteins is intended, TGE can replace costly and low-yield methods.
 
Full-Text [PDF 1080 kb]   (1196 Downloads)    
Type of Study: Research | Subject: Biotechnology
Published: 2018/05/15

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Research in Molecular Medicine

Designed & Developed by : Yektaweb